Christopher Alfieri is a Thought Leader Liaison in Neurology & Immunology at EMD Serono. In this role, he has covered KOLs in New York, New Jersey, Pennsylvania, Delaware, and Connecticut. Christopher is responsible for building and maintaining relationships with KOLs based on disease state conversations in the field, at speaker programs and at congresses.
He served EMD Serono in this role for the past four years. Christopher has deep insight into what makes a successful Thought Leader Liaison. He has also driven a number of projects in the field that have changed the dynamic of the KOL relationship.
Esq., Contracts Manager, Global Medical Operations
Jay Alkam – Esq., Contracts Manager, Global Medical Operations
Director, Global Aesthetics Scientific Communications
Jennifer Almekinder – Director, Global Aesthetics Scientific Communications
Senior Director, Global Medical Science Liaison
Kevin Appareti – Senior Director, Global Medical Science Liaison
Kevin Appareti is Senior Director, Global Medical Science Liaison in the Chief Medical Office at Royal Philips. He leads the Key Thought Leadership Program and works across Philips’ businesses, markets, and research to build strong internal and external relationships with key thought leaders and influencers. Kevin partners with internal business, market, and research leaders to develop strategic Key Thought Leader (KTL) engagement programs to deliver strategic guidance, leverage clinical and scientific knowledge, foster peer-to-peer relationships, and support clinical and marketing evidence development in support of Philips meaningful innovations.
Prior to the 7 years he has been in the Chief Medical Office, he had 25 years of experience in the Ultrasound Business Unit where he held a variety of leadership positions. He was senior marketing manager of the global luminary program where he contributed to establishing a structured approach to thought leader management. He was also worldwide market development manager and director of product marketing for cardiovascular ultrasound where he brought to market many cardiovascular ultrasound products that set the standard in performance and reliability. He has held additional positions in marketing management for professional services, information technologies and clinical marketing.
He began his academic, research and clinical career as Program Director for Diagnostic Medical Ultrasound Education at the University of Colorado Health Sciences Center where he was involved in clinical research in fetal echocardiography, neonatal brain imaging, and ultrasound technology assessment. He has co-authored many scientific papers, book chapters and presented at numerous international scientific conferences.
He then moved to an industry with various clinical and management roles with Hewlett Packard, Agilent Technologies, and now Royal Philips. Kevin holds a bachelor’s degree in physical science from Colorado State University and an MBA from Boston University and has been an adjunct professor at the University of Massachusetts at Lowell, Manning School of Business.
Kevin is married and has 4 boys. He enjoys basketball, road cycling, tennis and he is an avid photographer.
Jacqueline S. Armani, O.D., F.A.A.O., graduated from the New England College of Optometry, externed at Bascom Palmer and practiced at the VA as a primary care and ocular disease resident optometrist. Jackie has extensive experience training and mentoring residents and students and is a Fellow of the American Academy of Optometry. She joined industry following years of clinical practice as Executive Clinical Outcomes Specialist at Bausch and Lomb. Jackie is now a Medical Science Liaison at Alcon Surgical where she supports over 20 products in 6 product categories. Jackie’s career has included her medical mission in Colombia with VOSH and South Africa with OneSight Global. She resides in New York, volunteers on her alumni board, and loves to travel and plan events.
Director of Research and Sponsored Programs
Helene Bach – Director of Research and Sponsored Programs
Director, Medical Science Liaisons (Americas)
Lynn Bass – Director, Medical Science Liaisons (Americas)
Respiratory and Immunology, MSL, U.S. Field-Based Medical Affairs
Howard Berkowitz – Respiratory and Immunology, MSL, U.S. Field-Based Medical Affairs
Howard Dorfman – Distinguished Visiting Practitioner and Adjunct Professor
SETON HALL UNIVERSITY SCHOOL OF LAW
Howard L. Dorfman is Founder of H.L. Dorfman Pharmaceutical Consulting, LLC providing compliance, regulatory and risk management consulting services to pharmaceutical and biotech companies and law firms.
His areas of expertise include FDA regulatory law, fraud and abuse, health care compliance, risk management, corporate governance, and litigation.
Mr. Dorfman served as Vice President and General Counsel at Ferring Pharmaceuticals, Inc. in Parsippany, New Jersey where he was responsible for all legal matters relating to the U.S. affiliate of a Swiss-based global pharmaceutical and biotech company. Previously, he served as a Counsel in the Life Sciences group at Ropes & Gray LLP in New York where his practice focused on compliance and regulatory issues relating to the pharmaceutical, biotech, and medical device industries.
Prior to joining Ropes & Gray, Mr. Dorfman was the chief legal officer of the pharmaceutical division of Bayer Healthcare LLC. Before joining Bayer, he was a member of the Bristol-Myers Squibb legal department as Counsel in the Litigation group involved in defense of nationwide product liability litigation and later as Counsel to the US Medicines Group involved in regulatory, compliance and commercial work.
Mr. Dorfman is an adjunct professor at Seton Hall University School of Law and has lectured and published articles on a range of issues including compliance, regulatory and litigation. He is Editor and Contributing Author of the Practising Law Institute Pharmaceutical Compliance and Enforcement Answer Book, now in its fourth edition. He received his B.A. with honors from Yeshiva University and his J.D. degree from Brooklyn Law School.
Global Medical Affairs – Diabetes Care, BD
Dan Hennessy – Vice President Field Medical Affairs
Dan Hennessy, PhD, MS, MBA, is a VP of Medical Affairs at EMD Serono and has over 18 years track record of significant contributions to medical affairs and clinical development of hematology/oncology and other specialty drug therapies. Specifically, Dr Hennessy has experience in medical affairs, field medical (MSL, Field HEOR) medical communications, pharmaceutical services outsourcing, health economics and outcomes research, clinical development, and regulatory affairs. He has worked on FDA/EAMA submissions and launches in both liquid and solid tumors, non-malignant hematology, Multiple Sclerosis, virology, medical devices, and orphan genetic disorders. As a seasoned industry leader, Dr Hennessy has built medical affairs organizations; and led scientific teams that are responsible for evidence generation, scientific communications, Key Opinion Leader engagement, clinician education, and that capturing and analysis of scientific and competitive insights. Dr. Hennessy’s passion is to leverage medical affairs organizations to accelerate the clinical development process and to facilitate uptake of crucial scientific and medical information to ensure adoption of novel therapeutic interventions into clinical practice. Ensuring that the right patient gets the right drug at the right time is a key driver for Dr. Hennessy.
Luchy Hidalgo – Independent Consultant
H Jen, M.D.
Executive Director, Oncology Global Medical Affairs, Head and Neck, Melanoma, and Hematology
Lai Jen – Executive Director, Oncology Global Medical Affairs, Head and Neck, Melanoma, and Hematology
L. Johnson, Pharm.D.
Director, Global Medical Excellence
Tonya Johnson, Pharm.D. – Director, Global Medical Excellence
Ariel Katz – CEO
ONC Investigator Initiated Trials Project Manager
ELI LILLY AND COMPANY
Jeremy Keeton – ONC Investigator Initiated Trials Project Manager
ELI LILLY AND COMPANY
Kelton, J.D., Pharm.D., MPH
Executive Director, R&D and Quality Counsel
Teresa Kelton – Executive Director, R&D and Quality Counsel
Sheila Komara – Senior MSL
Associate Director, Clinical Operations Lead I/O Hematology, NRDG
John Lee – Associate Director, Clinical Operations Lead I/O Hematology, NRDG
Executive Director, Medical Affairs Strategy
Barry Lubarsky – Executive Director, Medical Affairs Strategy
Kate Pietrovito – Senior Director, Medical Affairs Operations
She oversees Medical Information, Medical Communications, Investigator Initiated Studies, and Grants across Interventional Medicine products. Previous to BTG, Kate was the first Medical Affairs hire in two separate organizations: Hologic and AngioDynamics, where she worked alongside Medical Directors to create highly functioning departments. Due to this experience, Kate brings a diverse medical affairs background to her role, with direct experience in field and medical information management, publications, investigator initiated trial oversight, and medical education. Kate also worked at Cubist Pharmaceuticals prior to it’s acquisition by Merck.
Kate holds a BS from Worcester Polytechnic Institute in Biology and Technical Communication, as well as an MS from Boston University in Health Communication. She is a certified as a Medical Writer by the American Medical Writers Association.
Kate lives in Central Massachusetts with her husband and their 8 year old son. She is an avid marathoner and cyclist.
Alan Polnariev – MSL
Director, Professional Relations and Customer Insights
Ann Roen – Director, Professional Relations and Customer Insights
Assoc. Vice President, U.S. Medical Affairs- Facial Aesthetics Therapy Area Lead
Sara Sangha – Assoc. Vice President, U.S. Medical Affairs- Facial Aesthetics Therapy Area Lead
Stone, Ph.D., BCMAS
Vice President, Medical Affairs
Archie Stone, PhD, is Vice President of Medical Affairs at Alcresta Therapeutics, Inc. Archie has 17 years of experience across the pharmaceutical, medical device and biotechnology industries. His industry expertise covers many different therapies and technology including oral drugs, injectable biologics, and medical devices across many disease states.
He has worked in various executive positions within the Medical Affairs departments of start-ups to mid-size healthcare organizations. Prior to joining Alcresta Therapeutics in 2016, he was the Senior Director of Medical Affairs at Sirtex Medical, Inc where oversaw creation of a patient registry to track outcomes of patient receiving SIR-Spheres therapy to treat inoperable liver tumors. Today that registry has collected clinical and outcomes data on over 1200 patients with liver cancer making it the largest interventional oncology database in the world. He has also been an invited lecturer meetings on managing and training medical science liaisons as well as conducting comparative effectiveness research for different cancer treatment modalities.
Dr Stone earned his Doctorate degree in Biochemistry and Molecular Biology in 2000 at the University of Arkansas for Medical Sciences in Little Rock.
Vice President, Global Medical Affairs
Sudeesh Tantry – Vice President, Global Medical Affairs
Valliere, Pharm.D., M.Sc.
Director, Neurology Medical Science Liaison Team Lead — East, Clinical Research and Medical Affairs
Steve Valliere – Director, Neurology Medical Science Liaison Team Lead — East, Clinical Research and Medical Affairs
Medical Science Liaison
Josh Yoder, Ph.D – Medical Science Liaison
Rita Zambelas – Associate Director
Vice President, Medical Affairs
Steven Zhang – Vice President, Medical Affairs
Externally Sponsored Research Manager and Clinical Study Leader
Cynthia Zinman – Externally Sponsored Research Manager and Clinical Study Leader